Toll-like receptors in the gonads and reproductive tract: Emerging roles in reproductive physiology and pathology

Immunology and Cell Biology

Volumn 85, Issue 6, 2007, Pages 481-489

  Girling, Jane E ^a,b   Hedger, Mark P ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cancer; Gametogenesis; Infertility; Inflammation; Pregnancy; Prostate

Indexed keywords

TOLL LIKE RECEPTOR;

EPIDIDYMIS; FEMALE GENITAL SYSTEM; GENITAL SYSTEM; GONAD; HUMAN; MALE GENITAL SYSTEM; OVARY; OVARY CANCER; OVIDUCT; PATHOLOGY; PELVIC INFLAMMATORY DISEASE; PHYSIOLOGY; PROSTATE; PROSTATE CANCER; PROSTATITIS; REPRODUCTION; REVIEW; TESTIS FUNCTION; UTERINE CERVIX; UTERINE TUBE; VAGINA; VAS DEFERENS;

ANIMALS; FEMALE; GENITALIA; GONADS; HUMANS; MALE; TOLL-LIKE RECEPTORS;

EID: 34548428385     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100086     Document Type: Review

References (114)

1. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
2. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD et al. The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci USA 2005; 102: 9577-9582.
3. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 1522-1526.
4. Zhang Z, Schluesener HJ. Mammalian toll-like receptors: from endogenous ligands to tissue regeneration. Cell Mol Life Sci 2006; 63: 2901-2907.
5. Richards JS, Russell DL, Ochsner S, Espey LL. Ovulation: new dimensions and new regulators of the inflammatory-like response. Ann Rev Physiol 2002; 64: 69-92.
6. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168: 554-561.
7. Shimada M, Hernandez-Gonzalez I, Gonzalez-Robanya I, Richards JS. Induced expression of pattern recognition receptors in cumulus oocyte complexes: novel evidence for innate immune-like functions during ovulation. Mol Endocrinol 2006; 20: 3228-3239.
8. Chen R, Alvero AB, Silasi DA, Mor G. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol 2007; 57: 93-107.
9. Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364: 1789-1799.
10. Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 2006; 66: 3859-3868.
11. Molteni M, Marabella D, Orlandi C, Rossetti C. Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4. Cancer Lett 2006; 235: 75-83.
12. Quayle AJ. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol 2002; 57: 61-79.
13. Itoh H, Nasu K, Nishida M, Matsumoto H, Yuge A, Narahara H. Human oviductal stromal fibroblasts, but not oviductal epithelial cells, express Toll-like receptor 4: the site-specific mucosal immunity of the human fallopian tube against bacterial infection. Am J Reprod Immunol 2006; 56: 91-101.
14. Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharmaceut Bull 2005; 28: 886-892.
15. Barrett S, Taylor C. A review on pelvic inflammatory disease. Int J STD AIDS 2005; 16: 715-720.
16. Pioli PA, Amiel E, Schaefer TM, Connolly JE, Wira CR, Guyre PM. Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 2004; 72: 5799-5806.
17. Fazeli A, Bruce C, Anumba DO. Characterization of Toll-like receptors in the female reproductive tract in humans. Human Reprod 2005; 20: 1372-1378.
18. Derbigny WA, Kerr MS, Johnson RM. Pattern recognition molecules activated by Chlamydia muridarum infection of cloned murine oviduct epithelial cell lines. J Immunol 2005; 175: 6065-6075.
19. Nasu K, Itoh H, Yuge A, Nishida M, Narahara H. Human oviductal epithelial cells express Toll-like receptor 3 and respond to double-stranded RNA: fallopian tube-specific mucosal immunity against viral infection. Human Reprod 2007; 22: 356-361.
20. Darville T, O'Neill JM, Andrews Jr CW, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003; 171: 6187-6197.
21. Salamonsen LA, Zhang J, Brasted M. Leukocyte networks and human endometrial remodelling. J Reprod Immunol 2002; 57: 95-108.
22. Salamonsen LA. Tissue injury and repair in the female human reproductive tract. Reproduction 2003; 125: 301-311.
23. Hirata T, Osuga Y, Hirota Y, Koga K, Yoshino O, Harada M et al. Evidence for the presence of toll-like receptor 4 system in the human endometrium. J Clin Endocrinol Metab 2005; 90: 548-556.
24. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004; 112: 428-436.
25. Soboll G, Shen L, Wira CR. Expression of Toll-like receptors (TLR) and responsiveness to TLR agonists by polarized mouse uterine epithelial cells in culture. Biol Reprod 2006; 75: 131-139.
26. Young SL, Lyddon TD, Jorgenson RL, Misfeldt ML. Expression of Toll-like receptors in human endometrial epithelial cells and cell lines. Am J Reprod Immunol 2004; 52: 67-73.
27. Jorgenson RL, Young SL, Lesmeister MJ, Lyddon TD, Misfeldt ML. Human endometrial epithelial cells cyclically express Toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA. Human Immunol 2005; 66: 469-482.
28. Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol 2005; 174: 992-1002.
29. Schaefer TM, Fahey JV, Wright JA, Wira CR. Migration inhibitory factor secretion by polarized uterine epithelial cells is enhanced in response to the TLR3 agonist poly (I:C). Am J Reprod Immunol 2005; 54: 193-202.
30. Soboll G, Crane-Godreau MA, Lyimo MA, Wira CR. Effect of oestradiol on PAMP-mediated CCL20/MIP-3 α production by mouse uterine epithelial cells in culture. Immunology 2006; 118: 185-194.
31. Verstak B, Hertzog P, Mansell A. Toll-like receptor signalling and the clinical benefits that lie within. Inflamm Res 2007; 56: 1-10.
32. Eriksson M, Meadows SK, Basu S, Mselle TF, Wira CR, Sentman CL. TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J Immunol 2006; 176: 6219-6224.
33. Meadows SK, Eriksson M, Barber A, Sentman CL. Human NK cell IFN-γ production is regulated by endogenous TGF-β. Int Immunopharmacol 2006; 6: 1020-1028.
34. Eriksson M, Meadows SK, Wira CR, Sentman CL. Endogenous transforming growth factor-β inhibits toll-like receptor mediated activation of human uterine natural killer cells. Am J Reprod Immunol 2006; 56: 321-328.
35. Weischer M, Friis-Moller A, Bremmelgaard A. Infections related to the menstrual cycle. A study of five otherwise healthy women with recurrent abscesses and a review of the literature. Infection 1994; 22: 395-400.
36. Wira CR, Fahey JV, White HD, Yeaman GR, Givan AL, Howell AL. The mucosal immune system in the human female reproductive tract: influence of stage of the menstrual cycle and menopause on mucosal immunity in the uterus. In: Glasser SR, Aplin J, Giudice LC, Tabibzadeh S (eds). The Endometrium. Taylor and Francis: London, 2002, pp 371-404.
37. Hirata T, Osuga Y, Hamasaki K, Hirota Y, Nose E, Morimoto C et al. Expression of toll-like receptors 2, 3, 4, and 9 genes in the human endometrium during the menstrual cycle. J Reprod Immunol 2007; 74: 53-60.
38. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O et al. The preterm parturition syndrome. Br J Obst Gynaecol 2006; 113 (Suppl 3): 17-42.
39. von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002; 81: 642-648.
40. Willoughby Jr RE, Nelson KB. Chorioamnionitis and brain injury. Clin Perinatology 2002; 29: 603-621.
41. Abrahams VM, Bole-Aldo P, Kim YM, Straszewski-Chavez SL, Chaiworapongsa T, Romero R et al. Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol 2004; 173: 4286-4296.
42. Chuang TH, Ulevitch RJ. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 2000; 11: 372-378.
43. Klaffenbach D, Rascher W, Rollinghoff M, Dotsch J, Meissner U, Schnare M. Regulation and signal transduction of toll-like receptors in human chorioncarcinoma cell lines. Am J Reprod Immunol 2005; 53: 77-84.
44. Holmlund U, Cebers G, Dahlfors AR, Sandstedt B, Bremme K, Ekstrom ES et al. Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology 2002; 107: 145-151.
45. Canavan TP, Simhan HN. Innate immune function of the human decidual cell at the maternal-fetal interface. J Reprod Immunol 2007; 74: 46-52.
46. Beijar EC, Mallard C, Powell TL. Expression and subcellular localization of TLR-4 in term and first trimester human placenta. Placenta 2006; 27: 322-326.
47. Abrahams VM, Schaefer TM, Fahey JV, Visintin I, Wright JA, Aldo PB et al. Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I : C). Human Reprod 2006; 21: 2432-2439.
48. Abrahams VM, Mor G. Toll-like receptors and their role in the trophoblast. Placenta 2005; 26: 540-547.
49. Zhang J, Wei H, Wu D, Tian Z. Toll-like receptor 3 agonist induces impairment of uterine vascular remodeling and fetal losses in CBAxDBA/2 mice. J Reprod Immunol 2007; 74: 61-67.
50. Chan G, Guilbert LJ. Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor-α dependent manner. J Pathol 2006; 210: 111-120.
51. Elovitz MA, Wang Z, Chien EK, Rychlik DF, Phillippe M. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 2003; 163: 2103-2111.
52. Wang H, Hirsch E. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4. Biol Reprod 2003; 69: 1957-1963.
53. Kumazaki K, Nakayama M, Yanagihara I, Suehara N, Wada Y. Immunohistochemical distribution of Toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis. Human Pathol 2004; 35: 47-54.
54. Kim YM, Romero R, Oh SY, Kim CJ, Kilburn BA, Armant DR et al. Toll-like receptor 4: a potential link between 'danger signals, ' the innate immune system, and preeclampsia? Am J Obstet Gynecol 2005; 193: 921-927.
55. Abrahams VM, Visintin I, Aldo PB, Guller S, Romero R, Mor G. A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 2005; 175: 8096-8104.
56. Zhang J, Sun R, Wei H, Wu D, Tian Z. Toll-like receptor 3 agonist enhances IFN-γ and TNF-α production by murine uterine NK cells. Int Immunopharmacol 2007; 7: 588-596.
57. Ashkar AA, Yao XD, Gill N, Sajic D, Patrick AJ, Rosenthal KL. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J Infect Dis 2004; 190: 1841-1849.
58. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol 2002; 168: 2424-2432.
59. Soboll G, Schaefer TM, Wira CR. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse. Am J Reprod Immunol 2006; 55: 434-446.
60. Pivarcsi A, Nagy I, Koreck A, Kis K, Kenderessy-Szabo A, Szell M et al. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human β-defensin-2 in vaginal epithelial cells. Microbes Infect 2005; 7: 1117-1127.
61. Ashkar AA, Bauer S, Mitchell WJ, Vieira J, Rosenthal KL. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J Virol 2003; 77: 8948-8956.
62. Harandi AM, Eriksson K, Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J Virol 2003; 77: 953-962.
63. McCluskie MJ, Cartier JL, Patrick AJ, Sajic D, Weeratna RD, Rosenthal KL et al. Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxy-nucleotides and resiquimod (R-848). Antiviral Res 2006; 69: 77-85.
64. Shen H, Iwasaki A. A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN-based vaginal microbicide. J Clin Invest 2006; 116: 2237-2243.
65. Herbst-Kralovetz MM, Pyles RB. Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection. J Virol 2006; 80: 9988-9997.
66. Wang Y, Abel K, Lantz K, Krieg AM, McChesney MB, Miller CJ. The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol 2005; 79: 14355-14370.
67. Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharmaceut Bull 2005; 28: 886-892.
68. Riccioli A, Starace D, Galli R, Fuso A, Scarpa S, Palombi F et al. Sertoli cells initiate testicular innate immune responses through TLR activation. J Immunol 2006; 177: 7122-7130.
69. Palladino MA, Johnson TA, Gupta R, Chapman JL, Ojha P. Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract. Biol Reprod 2007; 76: 958-964.
70. Rodríguez-Martínez S, Cancino-Díaz ME, Jiménez-Zamudio L, García-Latorre E, Cancino-Díaz JC. TLRs and NODs mRNA expression pattern in healthy mouse eye. Br J Ophthalmol 2005; 89: 904-910.
71. + T cell response. Immunity 2006; 25: 655-664.
72. Lauw FN, Caffrey DR, Golenbock DT. Of mice and man: TLR11 (finally) finds profilin. Trends Immunol 2005; 26: 509-511.
73. Adamopoulos DA, Lawrence DM, Vassilopoulos P, Contoyiannis PA, Swyer GI. Pituitary-testicular interrelationships in mumps orchitis and other viral infections. Br Med J 1978; 1: 1177-1180.
74. Buch JP, Havlovec SK. Variation in sperm penetration assay related to viral illness. Fertil Steril 1991; 55: 844-846.
75. Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S. Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 1988; 31: 1314-1317.
76. Liew SH, Meachem SJ, Hedger MP. A stereological analysis of the response of spermatogenesis to an acute inflammatory episode in adult rats. J Androl 2007; 28: 176-185.
77. O'Bryan MK, Schlatt S, Phillips DJ, de Kretser DM, Hedger MP. Bacterial lipopolysaccharide-induced inflammation compromises testicular function at multiple levels in vivo. Endocrinology 2000; 141: 238-246.
78. Russell SH, Small CJ, Stanley SA, Franks S, Ghatei MA, Bloom SR. The in vitro role of tumour necrosis factor-α and interleukin-6 in the hypothalamic-pituitary gonadal axis. J Neuroendocrinol 2001; 13: 296-301.
79. Laflamme N, Echchannaoui H, Landmann R, Rivest S. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria. Eur J Immunol 2003; 33: 1127-1138.
80. Lohrer P, Gloddek J, Nagashima AC, Korali Z, Hopfner U, Pereda MP et al. Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38α mitogen-activated protein kinase/nuclear factor-κB pathway. Endocrinology 2000; 141: 4457-4465.
81. Wang J, Wreford NG, Lan HY, Atkins R, Hedger MP. Leukocyte populations of the adult rat testis following removal of the Leydig cells by treatment with ethane dimethane sulfonate and subcutaneous testosterone implants. Biol Reprod 1994; 51: 551-561.
82. Hutson JC. Interactions between testicular macrophages and Leydig cells. J Androl 1998; 19: 394-398.
83. Sun XR, Hedger MP, Risbridger GP. The effect of testicular macrophages and interleukin-1 on testosterone production by purified adult rat Leydig cells cultured under in vitro maintenance conditions. Endocrinology 1993; 132: 186-192.
84. Xiong Y, Hales DB. Immune - endocrine interactions in the mouse testis: cytokine-mediated inhibition of Leydig cell steroidogenesis. Endocr J 1994; 2: 223-228.
85. Pomerantz DK, Pitelka V. Nitric oxide is a mediator of the inhibitory effect of activated macrophages on production of androgen by the Leydig cell of the mouse. Endocrinology 1998; 139: 922-931.
86. Syed V, Gerard N, Kaipia A, Bardin CW, Parvinen M, Jegou B. Identification, ontogeny, and regulation of an interleukin-6-like factor in the rat seminiferous tubule. Endocrinology 1993; 132: 293-299.
87. Syed V, Stéphan JP, Gérard N, Legrand A, Parvinen M, Bardin CW et al. Residual bodies activate Sertoli cell interleukin-1α (IL-1α) release, which triggers IL-6 production by an autocrine mechanism, through the lipoxygenase pathway. Endocrinology 1995; 136: 3070-3078.
88. Stéphan JP, Syed V, Jégou B. Regulation of Sertoli cell IL-1 and IL-6 production in vitro. Mol Cell Endocrinol 1997; 134: 109-118.
89. Bauché F, Stéphan JP, Touzalin AM, Jégou B. In vitro regulation of an inducible-type NO synthase in the rat seminiferous tubule cells. Biol Reprod 1998; 58: 431-438.
90. Lee NP, Cheng CY. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3′, 5′-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study. Endocrinology 2003; 144: 3114-3129.
91. Hakovirta H, Syed V, Jégou B, Parvinen M. Function of interleukin-6 as an inhibitor of meiotic DNA synthesis in the rat seminiferous epithelium. Mol Cell Endocrinol 1995; 108: 193-198.
92. Hakovirta H, Pentitil TL, Pöllänen P, Fröysa B, Söder O, Parvinen M. Interleukin-1 bioactivity and DNA synthesis in X-irradiated rat testes. Int J Androl 1993; 16: 159-164.
93. Parvinen M, Söder O, Mali P, Fröysa B, Ritzén EM. In vitro stimulation of stage-specific deoxyribonucleic acid synthesis in rat seminiferous tubule segments by interleukin-1α. Endocrinology 1991; 129: 1614-1620.
94. Söder O, Syed V, Callard GV, Toppari J, Pöllänen P, Parvinen M et al. Production and secretion of an interleukin-1-like factor is stage-dependent and correlates with spermatogonial DNA synthesis in the rat seminiferous epithelium. Int J Androl 1991; 14: 223-231.
95. Hakovirta H, Kaipia A, Söder O, Parvinen M. Effects of activin-A, inhibin-A, and transforming growth factor-β1 on stage-specific deoxyribonucleic acid synthesis during rat seminiferous epithelial cycle. Endocrinology 1993; 133: 1664-1668.
96. Mather JP, Attie KM, Woodruff TK, Rice GC, Phillips DM. Activin stimulates spermatogonial proliferation in germ-Sertoli cell cocultures from immature rat testis. Endocrinology 1990; 127: 3206-3214.
97. Hoeben E, Wuyts A, Proost P, Van Damme J, Verhoeven G. Identification of IL-6 as one of the important cytokines responsible for the ability of mononuclear cells to stimulate Sertoli cell functions. Mol Cell Endocrinol 1997; 132: 149-160.
98. Nehar D, Mauduit C, Boussouar F, Benahmed M. Interleukin 1α stimulates lactate dehydrogenase A expression and lactate production in cultured porcine Sertoli cells. Biol Reprod 1998; 59: 1425-1432.
99. Gérard N, Syed V, Jégou B. Lipopolysaccharide, latex beads and residual bodies are potent activators of Sertoli cell interleukin-1α production. Biochem Biophys Res Commun 1992; 185: 154-161.
100. Okuma Y, O'Connor AE, Hayashi T, Loveland KL, de Kretser DM, Hedger MP. Regulated production of activin A and inhibin B throughout the cycle of the seminiferous epithelium in the rat. J Endocrinol 2006; 190: 331-340.
101. Yasuda K, Yu P, Kirschning CJ, Schlatter B, Schmitz F, Heit A et al. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and - independent pathways. J Immunol 2005; 174: 6129-6136.
102. Karik K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279: 12542-12550.
103. Zetterström CK, Strand ML, Söder O. The high mobility group box chromosomal protein 1 is expressed in the human and rat testis where it may function as an antibacterial factor. Hum Reprod 2006; 21: 2801-2809.
104. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006; 26: 174-179.
105. Malm J, Nordahl EA, Bjartell A, Sørensen OE, Frohm B, Dentener MA et al. Lipopolysaccharide-binding protein is produced in the epididymis and associated with spermatozoa and prostasomes. J Reprod Immunol 2005; 66: 33-43.
106. Mackern-Oberti JP, Maccioni M, Cuffini C, Gatti G, Rivero VE. Susceptibility of prostate epithelial cells to Chlamydia muridarum infection and their role in innate immunity by recruitment of intracellular Toll-like receptors 4 and 2 and MyD88 to the inclusion. Infect Immun 2006; 74: 6973-6981.
107. Quintar AA, Roth FD, De Paul AL, Aoki A, Maldonado CA. Toll-like receptor 4 in rat prostate: modulation by testosterone and acute bacterial infection in epithelial and stromal cells. Biol Reprod 2006; 75: 664-672.
108. Gatti G, Rivero V, Motrich RD, Maccioni M. Prostate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulation. J Leukoc Biol 2006; 79: 989-998.
109. Ilvesaro JM, Merrell MA, Swain TM, Davidson J, Zayzafoon M, Harris KW et al. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 2007; 67: 774-781.
110. Takeyama K, Mitsuzawa H, Shimizu T, Konishi M, Nishitani C, Sano H et al. Prostate cell lines secrete IL-8 in response to Mycoplasma hominis through Toll-like receptor 2-mediated mechanism. Prostate 2006; 66: 386-391.
111. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7: 256-269.
112. Zheng SL, Augustsson-Balter K, Chang B, Hedelin M, Li L, Adami HO et al. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results fromthe CAncer Prostate in Sweden Study. Cancer Res 2004; 64: 2918-2922.
113. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 2005; 65: 11771-11778.
114. Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L et al. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Nat Cancer Inst 2005; 97: 525-532.